Details for New Drug Application (NDA): 065407
✉ Email this page to a colleague
NDA 065407 describes TOBRAMYCIN SULFATE, which is a drug marketed by Apothecon, Baxter Hlthcare Corp, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Igi Labs Inc, Mylan Labs Ltd, Slate Run Pharma, Teva Pharms Usa, Watson Labs Inc, Xellia Pharms Aps, and Xgen Pharms, and is included in thirty-two NDAs. It is available from eleven suppliers. Additional details are available on the TOBRAMYCIN SULFATE profile page.
The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
Summary for 065407
| Tradename: | TOBRAMYCIN SULFATE |
| Applicant: | Mylan Labs Ltd |
| Ingredient: | tobramycin sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 065407
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 065407 | ANDA | Mylan Institutional LLC | 67457-428 | 67457-428-30 | 10 VIAL in 1 CARTON (67457-428-30) / 30 mL in 1 VIAL (67457-428-00) |
| TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 065407 | ANDA | Mylan Institutional LLC | 67457-473 | 67457-473-22 | 25 VIAL in 1 CARTON (67457-473-22) / 2 mL in 1 VIAL (67457-473-00) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML | ||||
| Approval Date: | Mar 11, 2008 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
